SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-18-008619
Filing Date
2018-06-15
Accepted
2018-06-15 16:28:36
Documents
2
Period of Report
2018-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4062
2 ex24fanucci.txt EX-24 4188
  Complete submission text file 0001179110-18-008619.txt   9726
Mailing Address MILLENNIUM PHARMACEUTICALS, INC. 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Fanucci Marsha (Reporting) CIK: 0001298814 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37813 | Film No.: 18902545

Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations